Prognosis of patients with residual pathological disease after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy and surgery for esophageal squamous cell carcinoma: a retrospective cohort study.
Mashiro OkunakaDaisuke KotaniHisashi FujiwaraKazuma SatoNaoto FujiwaraSaori MishimaShingo SakashitaTakayuki YoshinoTakeo FujitaTakashi KojimaPublished in: Therapeutic advances in medical oncology (2024)
In this largest-to-date cohort study, patients with residual pathological disease after neoadjuvant DCF followed by surgery for locally advanced ESCC had a poor prognosis. In these patients, pathological node positivity, including supraclavicular lymph node metastasis, and lymphovascular invasion were considered significant prognostic factors.
Keyphrases
- prognostic factors
- lymph node metastasis
- poor prognosis
- minimally invasive
- lymph node
- locally advanced
- rectal cancer
- squamous cell carcinoma
- coronary artery bypass
- long non coding rna
- end stage renal disease
- papillary thyroid
- chronic kidney disease
- ejection fraction
- newly diagnosed
- surgical site infection
- radiation therapy
- stem cells
- mesenchymal stem cells
- coronary artery disease
- percutaneous coronary intervention
- patient reported outcomes
- endometrial cancer
- smoking cessation